After removal of the warning, cephalosporin use increased from 17.9% to 27.0% at the intervention site. Removal of the default warning in the electronic health record (EHR) urging the avoidance of ...

Cephalosporin antibiotics are widely prescribed for common infections such as bronchitis, otitis media, pneumonia, and cellulitis. They are also administered as first-line prophylaxis for many types ...

Please provide your email address to receive an email when new articles are posted on . 49 of 50 patients with penicillin allergy tolerated 76 of 77 doses of cephalosporins. 70% of reactions were low ...

Please provide your email address to receive an email when new articles are posted on . I routinely see prescribers avoid prescribing cephalosporin antibiotics for patients with a penicillin allergy.

The Food and Drug Administration had planned to ban the use of a popular antibiotic from use in animal feed. At the last minute, the agency pulled back. Cephalosporin is one of the most important ...

Cephalosporins are a type of antibiotic that can treat a range of simple infections. People can take them orally or doctors can inject them into a vein. Cephalosporins are a type of antibiotic.

ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...

Deacetoxycephalosporin-C synthase (DAOCS) is a mononuclear ferrous enzyme that transforms penicillins into cephalosporins by inserting a carbon atom into the penicillin nucleus. In the first ...

Oral cefixime yielded similar rates of treatment success for early syphilis when compared with penicillin, according to preliminary results of a small randomized trial. At 3 or 6 months post-treatment ...

WASHINGTON – Cefiderocol (Fetroja) may be a viable targeted-therapy option in critically ill patients with carbapenem-resistant Acinetobacter baumannii infections (CRAB), according to the ongoing ...

Drug discontinued-text Specifically, the following presentations will no longer be available: 125mg/5mL; 100mL bottles (anticipated final date of availability: April 1, 2018), 250mg/5mL; 50mL bottles ...